繁體
简体中文
繁體中文

Gauzy Ltd. GAUZ

等待開盤 10-24 09:30:00 美东时间

6.41

+0.225

+3.64%

华盛通華盛通
立即下載
  • 最 高6.59
  • 今 開6.305
  • 成交量 4.35万股
  • 最 低 6.305
  • 昨 收 6.185
  • 總市值 1.20亿
  • 52周最高 13.00
  • 市盈率 --
  • 換手率 0.00%
  • 52周最低 4.54
  • 委 比 96.08%
  • 總股本 1873.39万
  • 歷史最高 17.10
  • 量 比 1.64
  • 振 幅 4.61%
  • 歷史最低 4.54
  • 每 手 1
  • 風險率 1.77%

個股概要

財務分析

公司資料

相關新聞

分紅派息

  • 分時圖
  • 日k
  • 周k
  • 月k

相關新聞

更多
  • Gauzy Debuts Its Next-Generation AI-Powered ADAS Technology for Buses, Smart-Vision® CMS at Busworld 2025

    Gauzy Ltd. introduced its next-generation Smart-Vision CMS at Busworld 2025, featuring AI-driven safety enhancements. The system, showcasing in Gauzy’s booth and on Yutong buses, integrates Ambarella’s CVflow AI SoCs for real-time object detection, adaptive overlays, and advanced driver assistance. With deployments in over 20,000 buses worldwide, Gauzy emphasizes bus safety and driver assistance, aligning with global Vision Zero initiatives. Core...

    10-06 13:24

  • Gauzy Ltd. Provides Update on Board of Directors

    Gauzy Ltd. announced that Michael Donnelly has resigned from its Board of Directors for personal reasons. Donnelly expressed gratitude for his time at Gauzy, highlighting the IPO and growth阶段. Gauzy’s CEO Eyal Peso thanked Donnelly for his contributions to the company’s growth and strategy. Donnelly confirmed no disagreements with the company and his decision was purely personal. Gauzy is a global leader in vision and light control technologies, ...

    09-16 21:00

  • Gauzy Ltd. to Attend B. Riley Securities Consumer & TMT Conference

    Gauzy Ltd. (Nasdaq: GAUZ), a global leader in vision and light control solutions, announced that its senior management will attend the B. Riley Securities Consumer & TMT Conference on September 10, 2025, in New York. Gauzy is a fully-integrated company focused on research, development, manufacturing, and marketing of innovative technologies for safe, sustainable, and comfortable user experiences across industries such as aerospace, automotive, an...

    09-04 12:00

  • Gauzy Selected as Exclusive Smart Glass Supplier to One of the Top 3 U.S. Financial Institutions for Nationwide Commercial Offices

    Gauzy Ltd. has been selected as the exclusive smart glass supplier for a Fortune 100 financial services leader, following rigorous testing. Initial installations have been completed across multiple U.S. locations, with a multi-phase rollout planned for additional sites. This partnership validates Gauzy's technology and supports its strategy to scale deployments in high-value institutional environments. The collaboration also highlights the compan...

    08-29 12:00

  • Barclays Maintains Overweight on Gauzy, Lowers Price Target to $10

    Barclays analyst Dan Levy maintains Gauzy (NASDAQ:GAUZ) with a Overweight and lowers the price target from $13 to $10.

    08-14 21:01

  • Gauzy Affirms FY2025 Sales Guidance of $130.000M-$140.000M vs $130.407M Est

    Gauzy (NASDAQ:GAUZ) affirms FY2025 sales outlook from $130.000 million-$140.000 million to $130.000 million-$140.000 million vs $130.407 million estimate.

    08-13 19:30

  • Gauzy Q2 2025 Adj. EPS $(0.67) Misses $(0.32) Estimate, Sales $20.054M Down From $24.409M YoY

    Gauzy (NASDAQ:GAUZ) reported quarterly losses of $(0.67) per share which missed the analyst consensus estimate of $(0.32) by 108.72 percent. This is a 23.86 percent increase over losses of $(0.88) per share from the same

    08-13 19:29

  • Earnings Scheduled For August 13, 2025

    Companies Reporting Before The Bell • Evotec (NASDAQ:EVO) is projected to repor...

    08-13 16:32

  • Gauzy Ltd. Approves Proposals and Announces Board Resignation

    Gauzy Ltd. ( ($GAUZ) ) has shared an announcement. On August 7, 2025, Gauzy Ltd...

    08-08 19:27

  • Gauzy Ltd. Announces Board of Directors Changes Following Annual Meeting

    Gauzy Ltd. announced that Alejandro Weinstein, a long-time investor and former Board member, has been elected to return to the Board of Directors, effective November 1, 2025. Weinstein, with over 30 years of experience in global management, including leading CFR Pharmaceuticals to a successful multi-billion-dollar sale to Abbott Laboratories, brings valuable expertise in global expansion, M&A, and public company governance. Eyal Peso, CEO and Cha...

    08-08 11:56